According to WiseGuy Reports, the Fungal Chitosan Market was valued at USD 354.0 million in 2024 and reached USD 396.9 million in 2025. The market is projected to grow to USD 1,250.0 million by 2035, registering a CAGR of 12.1% during the forecast period. Strong demand for biopolymers, expanding pharmaceutical applications, increasing awareness of sustainable materials, advancements in extraction technologies, and wider agricultural adoption are accelerating market growth. Major companies including KitoZyme, Chitinor, Laminaria Technology, Advanced Biotech, Heppe Medical Chitosan, Soehendra, Fountain Cosmetics, Sino Polymer, Primex EHF, Tianjin Mande Chemical, Zhejiang Yongsung, and Ginkgo BioWorks continue strengthening market competition through innovation and product development.

Market Overview

Fungal chitosan is a naturally derived biopolymer obtained from fungal sources such as mushrooms and yeasts. Unlike conventional chitosan derived from shellfish, fungal chitosan offers a sustainable and vegan-friendly alternative suitable for pharmaceutical, cosmetic, food, agricultural, and biotechnology applications. Its biocompatibility, biodegradability, and antimicrobial properties have expanded its commercial value across multiple industries.

Growing preference for renewable raw materials and environmentally responsible manufacturing practices continues to increase demand for fungal chitosan worldwide.

Market Size Reached in 2025

The Fungal Chitosan Market reached USD 396.9 million in 2025, supported by rising adoption across pharmaceutical manufacturing and nutraceutical production. Increasing investments in biotechnology research have accelerated demand for naturally sourced biopolymers with high purity and consistent quality.

Food preservation and cosmetic formulations have also contributed significantly to market expansion as manufacturers seek sustainable ingredients capable of enhancing product performance.

Expected Market Size by 2035

The market is expected to attain USD 1,250.0 million by 2035. Continued advancements in fungal cultivation technologies, growing consumer preference for plant-based ingredients, and expanding biomedical research are expected to sustain rapid market growth.

Agricultural applications utilizing fungal chitosan for crop protection and soil improvement are also anticipated to generate substantial commercial opportunities.

Market CAGR

The Fungal Chitosan Market is forecast to expand at a CAGR of 12.1% between 2026 and 2035. Continuous innovation in extraction technologies and increasing commercial acceptance of bio-based materials are expected to support strong long-term growth.

Manufacturers continue investing in production efficiency while improving product quality for high-value industrial applications.

Key Growth Drivers

Growing demand for biodegradable biopolymers remains a major growth driver as industries seek sustainable alternatives to synthetic materials. Pharmaceutical companies continue expanding the use of fungal chitosan in drug delivery systems, wound care products, and biomedical applications due to its excellent biocompatibility.

Agriculture is emerging as another important application area where fungal chitosan supports plant health and environmentally responsible crop management. Rising consumer demand for natural cosmetics and clean-label food products further strengthens market growth.

Emerging Market Trends

Manufacturers are developing high-purity fungal chitosan with enhanced functional properties suitable for advanced medical, cosmetic, and food applications. Research into innovative extraction methods is improving production efficiency while reducing environmental impact.

Growing investments in bioengineering and nutraceutical development continue expanding the commercial potential of fungal chitosan across multiple industries.

Competitive Landscape

The Fungal Chitosan Market remains competitive as manufacturers focus on sustainable production, technological innovation, and product diversification. Companies continue expanding research capabilities while strengthening global supply networks.

Leading companies including KitoZyme, Chitinor, Laminaria Technology, Advanced Biotech, Heppe Medical Chitosan, Soehendra, Fountain Cosmetics, Sino Polymer, Primex EHF, Tianjin Mande Chemical, Zhejiang Yongsung, and Ginkgo BioWorks continue developing advanced fungal chitosan solutions for pharmaceutical, agricultural, cosmetic, and biotechnology applications.

Supported by increasing sustainability initiatives, expanding biomedical applications, and growing demand for renewable biopolymers, the Fungal Chitosan Market is expected to experience strong growth through 2035.